The relative price valuations of Asian equities compared with their global peers are at a near 14-month low, data showed, after their lacklustre performance due to worries over slowing growth and the spread of the Delta-variant of coronavirus this year.
The MSCI Asia-Pacific index is up just 3.37per cent this year, compared with the MSCI United States' gain of 19.7per cent and MSCI Europe's 12.9per cent this year. "U.S. equities had an incredible run so far leading to almost 35per cent premium over Asian equities, higher than the average discount over the past 20 years," said Sean Taylor, chief investment officer for APAC at DWS.
Some analysts said Asian stocks are attractive at these levels and could stage a turnaround due to the recent pick up in vaccinations and a rise in domestic consumption levels in the region.